PV

Prasanth Valiyattoor

Active Director Director DIN 11374022
DIN 11374022 First appointment Nov 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Prasanth Valiyattoor

Data last updated:

Prasanth Valiyattoor is a Director at Solfos Pharmaceuticals Private Limited (since 2025). The company operates in Pharma.

DIN 11374022
Primary Designation Director
Industry Pharma
First Appointment 08 Nov 2025

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director08 Nov 20252025Active

Directorship timeline

Open interactive timeline →
Solfos Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Prasanth Valiyattoor

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Prasanth Valiyattoor

Prasanth Valiyattoor currently holds 1 directorship: Solfos Pharmaceuticals Private Limited (Director, since 08 Nov 2025).

Prasanth Valiyattoor was first appointed on 08 Nov 2025 as Director at Solfos Pharmaceuticals Private Limited.

The current boards of Prasanth Valiyattoor's companies include Gopalakrishnan Deepak (Solfos Pharmaceuticals Private Limited), Omassappuzha Vishwambharan Devidasan (Solfos Pharmaceuticals Private Limited), Prasad Ramachandran Nair (Solfos Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available